CARRUSEL | A year of challenges and experience with the New ERA guideline

The ERA is a mandatory component of all new Marketing Authorisation Applications (MAAs), regardless of the submission pathway or legal basis. Understanding this is key to ensuring that scientific, environmental, and regulatory considerations are properly integrated into a compliant and well-structured dossier.

Our team’s strong scientific and academic background in non-clinical, clinical, and CMC writing contributes to building development programs that meet regulatory expectations and support successful submissions.

Need support with your Development Writing or ERA activities? Contact us at: [email protected]